Buch, Englisch, 210 Seiten, Format (B × H): 183 mm x 260 mm, Gewicht: 603 g
Buch, Englisch, 210 Seiten, Format (B × H): 183 mm x 260 mm, Gewicht: 603 g
ISBN: 978-1-032-53007-9
Verlag: CRC Press
This reference book compiles the recent advances in computational and experimental modelling to screen and manage Alzheimer’s disease. It covers basic etiopathology and various in vitro and in vivo strategies of disease intervention. The book discusses how computer-aided drug design approaches reduce costs and increase biological test efficiency. It reviews the screening for anti-Alzheimer drugs and biomarker analysis of disease inhibitors. The book also explores mechanistic aspects of neurodegeneration and the use of natural products as therapeutics for Alzheimer’s disease.
Key features:
- Elaborates on the computational modelling of protein target inhibitors as anti-Alzheimer’s agents
- Explains the role of phytomolecules and natural products in Alzheimer’s therapy
- Reviews preclinical ways to assess drugs focusing on Alzheimer’s disease
- Covers biomarker analysis for Alzheimer’s disease
- Discusses the onset and progression of Alzheimer’s disease
The book is meant for professionals, researchers, and students of neuroscience, psychology, and computational neurosciences.
Zielgruppe
Academic, Postgraduate, and Professional Reference
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
- Interdisziplinäres Wissenschaften Wissenschaften Interdisziplinär Neurowissenschaften, Kognitionswissenschaft
- Sozialwissenschaften Psychologie Allgemeine Psychologie Biologische Psychologie, Neuropsychologie
Weitere Infos & Material
Chapter 1: Alzheimer's Disease: Epidemiology, Neuropathology, and Neurochemistry
Raushan Kumar Chaudhary, Uday Venkat Mateti, Pukar Khanal, Kala Bahadur Rawal, Praneetha Jain, Vishal S Patil, Amit Kumar Shrivastava and B M Patil
Chapter 2: Preclinical Approach: In vivo and In vitro Methods for Evaluation of Anti-Alzheimer's Drugs
Nilutpal Sharma Bora, Bhargab Jyoti Sahariah, Chanam Melody Devi and Banshongdor H. Mawlieh
Chapter 3: Computational Insights into the Applications of Plant-Based Therapies in Alzheimer's Disease
Dibyajyoti Das, Satyendra Deka, Biswajit Devanath, Aparoop Das, Nongmaithem Randhoni Chanu and Ramen Kalita
Chapter 4: Advances in Applying Computer-Aided Drug Design for Alzheimer’s Disease
Biswajit Devanath, Satyendra Deka, Dibyajyoti Das, Hans Raj Bhat, Nongmaithem Randhoni Chanu and Kunal Bhattacharya
Chapter 5: Biomarkers Analysis for Alzheimer's Disease
Shraddha M. Jadhav and Karan Kumar
Chapter 6: Mechanistic Aspects of Neurodegeneration in Alzheimer's Disease and the Role of Phytochemicals
Trideep Saikia, Tutumoni Kalita, Bhanu P Sahu, Prakash Rajak, Bhargab Deka and Alakesh Bharali
Chapter 7: Computational Modelling of BACE-1, AChE, and Phosphodiesterase Inhibitors as Anti-Alzheimer's Agents
Vishal S Patil, Jagadeesh Dodakallanavar, Pukar Khanal, B M Patil, Raushan K Chaudhary, Amit Kumar Shrivastava, Nongmaithem Randhoni Chanu, Darasaguppe R. Harish and Uday Venkat Mateti
Chapter 8: Therapeutic Application of Natural Products in Alzheimer’s Disease Using Computational Methods
Muhammad Aqib Shabbir, Muhammad Naveed, Maleeha Manzoor, Hafiz Muhammad Hurraira, Noor-ul-Ain and Fatima Zaidi
Chapter 9: Analysis of Potential Alzheimer's Disease Inhibitors Based on Computational Modelling with Multiple Targets
Ankita Dubey, Vrishti M Thakur, Raja Chakraborty, G.N. Darwhekar, Rupesh Kushwah and Rakhi Khabiya
Chapter 10: Virtual Screening: Pioneering the Future of Drug Discovery in Alzheimer's Disease
N. Yellasubbaiah, B. Sivakumar and B. Nagasudha
Index